We are live on
!
Find out more
Emergent Biosolutions
EBS
EBS
183 hedge funds and large institutions have $537M invested in Emergent Biosolutions in 2025 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 60 increasing their positions, 52 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
245% more call options, than puts
Call options by funds: $7.82M | Put options by funds: $2.27M
68% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 25
52% more capital invested
Capital invested by funds: $352M → $537M (+$184M)
15% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 52
8% more funds holding
Funds holding: 169 → 183 (+14)
4.5% more ownership
Funds ownership: 78.16% → 82.65% (+4.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
183
Holders Change
+14
Holders Change %
+8.28%
% of All Funds
2.23%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
42
Increased
60
Reduced
52
Closed
25
Calls
$7.82M
Puts
$2.27M
Net Calls
+$5.55M
Net Calls Change
-$369K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$6.74M |
| 2 |
JG
Jain Global
New York
|
+$4.65M |
| 3 |
D.E. Shaw & Co
New York
|
+$4.31M |
| 4 |
Jane Street
New York
|
+$4.24M |
| 5 |
HF
HRT Financial
New York
|
+$3.34M |
